What Is Breast Fat Grafting?
Breast fat grafting (also called lipofilling or autologous fat transfer to the breast) uses a patient's own fat, harvested by liposuction from another area of the body, to increase breast volume, improve shape, or correct asymmetry between the breasts. Because the material used is the patient's own living tissue rather than a synthetic implant, results tend to look and feel natural, and there is no risk of the implant-specific complications discussed below.
Mr Naparus does not offer implant-based breast augmentation or other cosmetic breast implant surgery. Fat grafting is the breast augmentation and asymmetry procedure he provides, and is offered where it is the right technique for a patient's goals and anatomy.
Breast Augmentation with Fat Grafting
Fat grafting can increase breast volume and improve upper pole fullness or cleavage, most successfully for patients seeking a modest, natural-looking increase — typically in the region of half to one cup size per session, depending on the amount of fat successfully grafted and retained. It is not able to achieve the scale of enlargement possible with a breast implant in a single procedure, and this is an important, honest distinction to understand before proceeding: patients seeking a large or dramatic increase in size are usually better served by implant-based augmentation, which Mr Naparus does not perform and would discuss referring on where appropriate.
Breast Asymmetry Correction
Fat grafting is particularly well suited to correcting breast asymmetry — where one breast is smaller, a different shape, or sits differently to the other — by adding volume selectively to the smaller or less full breast to improve overall balance, without needing to operate on the larger side. This is often one of the most rewarding applications of the technique, as even a modest, precisely placed volume correction can make a significant difference to symmetry and confidence.
Who Is a Good Candidate?
- Patients seeking a modest, natural increase in breast volume, rather than a dramatic change in size
- Patients with breast asymmetry seeking to balance one side against the other
- Patients who wish to avoid a synthetic implant, or who are not candidates for implant surgery
- Patients with adequate donor fat available for harvest
- Patients with realistic expectations about the volume achievable, and an understanding that more than one session may be needed
Not everyone is a good candidate. Patients seeking a substantial increase in breast size, those with very little donor fat available, and those who prioritise achieving a specific size in a single procedure are generally not well suited to fat grafting alone, and this is discussed honestly at consultation.
The Procedure
Performed under general anaesthetic as a day case or with a short stay. Fat is harvested by gentle liposuction from a donor area such as the abdomen, flanks or thighs — with the added benefit of some body contouring at the donor site — then processed to separate viable fat cells, and re-injected into the breast in many small, precise deposits across multiple layers and tissue planes. This meticulous technique is central to maximising graft survival and avoiding lumps, oil cysts or an unnatural result.
Success Rates & Volume Retention
As with fat grafting elsewhere in the body, not all transferred fat survives permanently — a proportion is reabsorbed in the months after surgery, while the remainder establishes a blood supply and survives long-term. Published survival rates for breast fat grafting vary by technique and study, broadly in the range of 40–70%, and results are not fully assessable until swelling has resolved and the graft has settled, usually by around three to six months. Many patients achieve their desired result with a single well-planned session; others, particularly those seeking a larger increase, choose a second, staged session to build on the first once it has stabilised.
BIA-ALCL: An Implant-Specific Risk That Fat Grafting Does Not Carry
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a rare cancer of the immune system that has been linked to breast implants — most strongly to certain textured (rather than smooth) implant surfaces. It typically presents as delayed fluid collection or swelling around an implant, often years after surgery, and is generally treatable when identified and managed appropriately.
Because breast fat grafting does not involve placing any implant or foreign device in the body, it does not carry any BIA-ALCL risk. For patients who are specifically concerned about this implant-associated risk, or who wish to avoid synthetic material in the breast altogether, this is a genuine and relevant advantage of fat grafting over implant-based augmentation.
Research & Evidence for Safety
Fat grafting to the breast has a more considered history than most cosmetic techniques. In 1987, the American Society of Plastic Surgeons (ASPS) advised against fat grafting to the breast, largely over concern that resulting calcifications and scarring might be mistaken for, or obscure, breast cancer on subsequent mammography. This early caution shaped practice for over two decades.
Following a substantial body of subsequent research, the ASPS Fat Graft Task Force revisited this position in 2009, concluding that fat grafting to the breast is a reasonable technique for breast augmentation and reconstruction when performed by appropriately trained surgeons, and that imaging changes such as oil cysts and calcifications are, in the great majority of cases, distinguishable from malignancy by an experienced radiologist. This conclusion has been supported by further studies since, and fat grafting to the breast is now an accepted, widely practised technique internationally.
Fat grafting can produce benign changes on future mammography — most commonly oil cysts and calcifications — that a radiologist needs to be able to distinguish from more concerning findings. You should always tell any radiologist or breast clinician performing future breast imaging that you have had fat grafting to the breast, so your scans can be interpreted correctly and any follow-up imaging planned appropriately.
Recovery
Swelling is often significant for the first one to two weeks and can temporarily overstate the eventual result — this settles as swelling resolves. Bruising is expected at both the breast and donor sites. Most patients return to non-strenuous activity within a week to ten days, with more complete settling over four to six weeks, and a supportive, non-underwired bra is usually worn during initial recovery.
Risks
Some graft volume is lost as part of normal healing; final results are assessed once this has settled.
A small proportion of grafted fat can form a firm nodule or cyst; usually managed conservatively, but should always be disclosed for future imaging.
Lumps or asymmetry can occur, particularly with less meticulous injection technique.
Can occur at the graft site and are relevant to future mammography — always disclose your surgical history.
Uncommon with sterile technique; more likely with fat necrosis or haematoma.
Some patients, particularly those seeking greater volume, choose a second, staged session.